SCHEMBL10093057

SCHEMBL10093057

CCC(C)c1cccc(NS(=O)(=O)c2ccc(-c3ccc(F)cc3F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ESR1 P03372 1/20 0.46
MCL1 Q07820 2/20 0.43
GRIA4 P48058 1/20 0.43
PHGDH O43175 1/20 0.42
TDO2 P48775 2/20 0.42
PTGES2 Q9H7Z7 1/20 0.42
ALOX12 P18054 1/20 0.42
AVPR2 P30518 1/20 0.42
GPR27 Q9NS67 1/20 0.42
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KCNA5 P22460 1/20 0.41
KCNH2 Q12809 1/20 0.41
KIT P10721 1/20 0.41
HDAC4 P56524 1/20 0.41
SCN9A Q15858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20117530 0.91 L3MBTL1 (0.46) ALDH1A1L3MBTL1ESR1MCL1GRIA4
SCHEMBL10093362 0.89 L3MBTL1 (0.46) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2236007 0.86 MCL1 (0.45) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2241472 0.86 MCL1 (0.45) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2234241 0.86 MCL1 (0.45) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL13464223 0.86 AVPR2 (0.42) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2238392 0.85 AVPR2 (0.43) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2235893 0.85 AVPR2 (0.43) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL2241347 0.85 AVPR2 (0.43) ALDH1A1L3MBTL1ESR1MCL1PHGDH
SCHEMBL20117809 0.84 PTGES2 (0.44) ALDH1A1L3MBTL1ESR1MCL1PHGDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207167-B2 Aryl-phenyl-sulfonamide-phenylene compounds and their use PIMCO 2664 LIMITED (GB) 2012-06-26 US disclosed
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use PIMCO 2664 LIMITED (GB) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190302-A1 Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use SOST, PSAP, ARSA ALDH1A1 1417/4885L3MBTL1 2194/4885ESR1 904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.